Radiotherapy and androgen deprivation in combination after local surgery. A randomised controlled trial in prostate cancer
Which treatments work best after prostate cancer surgery?
What is this study about?
Around 10,000 men with prostate cancer have surgery to remove their prostate in the UK and Canada every year. There is currently no agreement on the best way of treating these men after surgery. Doctors take many different approaches. This trial aims to decide whether it’s best to give men radiotherapy straight after surgery, or wait until there are signs that the cancer may be growing again. The trial also aims to decide whether a man having radiotherapy should also have hormone therapy and if so, for how long.
<div style="padding: 56.25% 0 0 0; position: relative;"><iframe src="https://www.youtube.com/embed/FpnQ1q68OuQ" style="position: absolute; top: 0; left: 0; width: 100%; height: 100%;" frameborder="0" allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen=""></iframe></div>
Type of study
Who is funding the study?
The trial is being paid for by the Medical Research Council and the charity Cancer Research UK.
When is it taking place?
Recruitment to the trial ended in 30th December 2016.
Where is it taking place?
Hospitals throughout the UK, Canada, Denmark and Ireland.
Who is included?
Men who have prostate cancer and surgery to remove their prostate.